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Abstract 
The war on drugs is usually associated with criminal policies aimed at stemming 
consumption of drugs such as heroin, cocaine, and cannabis, less so with 
enhancement drugs like those used in sport.  As drug use in sport, or doping, has 
become more visibly widespread, policies aimed at combating the issue have 
become more restrictive, intrusive, and harsh.  In this article we draw new 
comparisons between the wider war on drugs and recent developments in sports 
anti-doping. We identify a growing trend towards criminalisation of traffickers and 
users, and associate that with another growing trend: the testing of amateur 
athletes. This article reviews the current anti-doping system, including the recent 
amateur policies, then considers of the results of one such program in amateur 
cycling.  We then shift to consider the possible implications for amateurs of 
criminal doping laws and the recent debates about allowing medical exemptions 
for therapeutic use of banned substances. We show that drug use in sport can be 
understood as a new front in the war on drugs, with some extreme measures and 
many negative unintended consequences. To remedy this, we argue that 
amateur athletes require a separate anti-doping policy focused on minimising 








 The phrase ‘war on drugs’ is most often used in connection with national 
policies targeting socially problematic drugs like heroin, cocaine, and cannabis. 
Regulations criminalising suppliers and users are the strategies of this war, and 
the problem is broadly assumed to be definable. Critical researchers challenge 
both that latter assumption and the methods used to police and punish 
producers, dealers, and consumers. Within that body of work the war on drugs 
paradigm, as both policy instrument and critical discourse, is not immediately 
applicable to sports. There are three likely reasons for this: 
i) sports drugs policy (anti-doping) outcomes have not had implications for other 
fields of social life: policing resources, criminal law proceedings, increase in 
prison populations; 
ii) drugs used in sports contexts are not always those demonized and 
problematised in wider society; 
iii) anti-doping policy is popularly seen as a necessary antidote to systematic 
cheating and corruption, and anti-doping agencies are thus seen as making a 
positive social contribution.  
 As harsh drug non-sport policies seem to be waning in some corners of 
the world, in recent years doping, and the attempts to regulate it, has moved to 
the centre of conversation on sport. Calls for increased surveillance of athletes 
and harsher penalties grew in volume and frequency in the lead up to the 2016 
Summer Olympics, as scandals involving state-sponsored doping in Russia 
(McLaren, 2016), the hacking of the World Anti-Doping Agency’s athlete 
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database (WADA, 2016), and the re-testing of anti-doping samples from Olympic 
Games dating back to 2008 that led to multiple retroactive disqualifications (IOC, 
2016). Efforts to address anti-doping shifted towards criminalising doping at the 
national level.  Laws criminalising various doping-related activities already 
existed in several countries (Murphy, 2013), but in 2016 Kenya approved a law 
including penalties for use (Mygov, 2016) and the United Kingdom’s Parliament 
debated a proposed amendment to criminalise doping (BBC, 2016).  Hacked 
medical records brought new scrutiny to athletes’ use of medical waivers, known 
in sport as therapeutic use exemptions (TUEs), in order to use a banned 
substance without facing penalty. Similarly to the war on drugs debate, the policy 
tools used have been criticised by researchers (Kasyer, Mauron & Miah, 2007; 
Moller, 2014), but the organisations responsible for controlling doping continue to 
follow the road of enhanced surveillance, testing, and punishments, regardless of 
the high numbers of inadvertent positives (de Hon, 2016). 
 Criminalising doping and questioning the TUE system are not new 
debates in sport.  What is different in anti-doping efforts in recent years, however, 
is the shift away from the elite athlete focus towards amateur and recreational 
athletes. The same rules that were designed to stop doping among international-
level athletes are being transferred to non-elite, amateur sporting communities. 
Two major sports organisations in the United States, USA Cycling (USAC) and 
New York Road Runners (NYRR), made changes to their anti-doping programs 
that put a new focus on testing non-elite competitors in 2016.  Other sport 
organizations, such as the International Triathlon Union and the International 
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Boxing Association, have had amateur testing programs for several years.  
Including amateurs may not seem problematic at the outset, as expecting 
athletes to follow rules about substance use seems reasonable. As with many 
punitive-based drug policies, the consequences of including amateurs in a 
system designed for elite athletes are much more complex.  Adding in the 
renewed focus on criminal doping laws and critiques of the TUE system, these 
new amateur testing programs carry legal, social, and health risks for athletes 
that go beyond sport. 
 These policies and their implications for amateur athletes are the focus of 
this article.  We begin with an overview of the reasons for and development of 
the current anti-doping system, including the recent amateur policies.  From there 
we consider the results USAC’s testing program has had so far for athletes who 
tested positive.   We then shift to consider the possible implications of criminal 
laws for amateurs, using the Kenyan law and debate in the U.K. as cases, and 
the recent debate around the validity of TUEs.  We argue that anti-doping 
agencies and sports federations need a separate policy for amateur athletes 
focused on minimising harms of use through targeted education and a health-
focused approach.  
Approach 
 This article builds upon early case study work by the authors (Henning 
and Dimeo, 2015), which used media coverage and arbitration documents to 
contextualise and classify specific anti-doping cases. We aim here to extend that 
discussion by drawing upon discourses of drug criminalisation and legalisation in 
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both sports and social drug use. To do so, we develop a macro-level analysis of 
global issues through media and policy sources. We analyze anti-doping policies 
developed by the World Anti-Doping Agency (WADA), cases involving amateur 
athletes tested under current policies, and new proposals for further escalating 
rules on doping in sport.  In our analysis of WADA policies we used the WADC 
and Prohibited Substances List, which are the foundational documents governing 
the global anti-doping program.  Drawing on the historical development of anti-
doping policies and critiques of the resultant system, we provide a review of the 
rationale for the policies as they stand, and the underpinning philosophy of anti-
doping.  We then review the policies regarding anti-doping testing for amateur 
athletes developed by USAC and NYRR.  
 Though sports such as boxing and weightlifting include high-level 
amateurs in their testing programs, and student-athletes are tested in inter-
university competition, USAC and NYRR include competitive amateurs as well as 
recreational participants.  The large majority of participants do not seek to place 
among the top competitors at events, and may participate for reasons completely 
unrelated to winning. These athletes represent the full range of ages, 
experiences, motivations, and lifestyles.  Amateurs, then, cannot be considered 
as a homogenous bloc or as necessarily similar to elites.  Further, these 
organisations oversee many mass participation events each year that attract 
thousands of participants to each, making their impact immediate and relevant 
for a large number of amateurs. For these reasons we examine how these two 
policies will be implemented and their rationale. 
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 Following this, we examine two developments within anti-doping: the use 
of national level criminal laws to deter and punish doping among athletes and the 
debates around the legitimacy of the TUE system.  We draw on media coverage 
from news outlets of record providing reports of the criminal law development in 
Kenya and proposals in the U.K. Parliament.  These reports were analyzed for 
background to the proposals, specific policy proposals put forth by government 
officials, any ensuing debate, and the evidence or argument offered by any 
officials or stakeholders.    
 One of the central challenges of policy case studies is pre-defining 
sources of information and modes of analysis.  As outlined above, several key 
sources are publicly available documents which allowed us to understanding the 
policy frameworks and institutional arrangements that support, guide and help 
implement anti-doping.  These documents pertain to global sport, national 
governments and localised sporting agencies.  The emergence of increased anti-
doping at amateur levels is in fact a localised decision within a global paradigm.  
Media sources have proved very helpful in highlighting cases where these 
decisions are made, and are manifest in testing and sanctioning of athletes.  
Methodologically, we need to treat such sources with healthy scepticism, seeking 
to cross-reference facts where possible, and avoiding the simple repetition of 
basic claims and subjective inferences.  Thereafter, we found information on the 
websites of sports organizations (for example, decisions to sanction specific 
athletes), we checked blogs and other internet forums for other insights, and 
where available reviewed arbitration documents.  In essence, we took a case 
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study approach, being led by the questions, and searching for adequate sources 
which, due to the sensitive nature of the subject, are not always fully open and 
transparent.   
 
Background: Drug use in sport 
 Anti-doping efforts are based on a strategy of surveillance, detection, and 
punishment, similar to aspects of the war on drugs.  Researchers have noted the 
links between efforts to stem illicit drugs outside of sport and the development of 
anti-doping policies within sport (Coomber, 2013; Dimeo, 2009; Hoberman, 2005; 
Møller, 2009).  Doping substances were not always banned in sport, as they 
were accepted in professional sports during the first half of the 20th century 
(Christiansen, 2010).  However, use of performance enhancing drugs (PEDs), or 
doping, was considered to directly conflict with amateur sporting values 
(Christiansen, 2010; Gleaves and Llewellyn, 2014).  Gleaves and Llewellyn 
(2014) detail the early regulations around doping, going as far back as the 1920s. 
These early efforts paved the way for later regulations beginning in the 1960s 
and expanding through the doping scandal-ridden decades of the 70s, 80s, and 
90s, such as Ben Johnson’s positive test at the 1988 Olympics and the 1998 
Festina Affair at the Tour de France (Gleaves and Llewellyn, 2014).  These 
culminated with the creation of WADA in 1999.    
 The current approach to doping parallels the legalistic prohibitionist 
approaches of war on drugs policies (Mazanov, 2013; Stewart & Smith, 2010). 
The World Anti-Doping Code (WADC), which went into effect in 2004, indicates 
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that anti-doping’s purpose is to preserve the ‘spirit of sport’, which it calls an 
‘intrinsic value’ of sport and encompasses values such as ethics, health, 
dedication, joy, and respect for others (WADA, 2015: 11). Researchers have 
critiqued the spirit of sport as an unclear concept underpinning anti-doping 
(Mazanov & Conner, 2010; Smith & Stewart, 2015; Waddington, Christiansen, 
Gleaves, Hoberman & Møller, 2013).  Further critique has been levelled against 
the inclusion of health as a reason for banning a substance, based on the 
paternalism of this approach (Kayser & Broers, 2012) as well as the lack of 
practical health promotion or protection for athletes afforded by anti-doping 
(Henning, 2016; Kayser & Smith, 2008).  The WADC details anti-doping rule 
violations (ADRV), of which there are ten types (WADA, 2015).  Only two of 
these involve actual use or attempted use of a banned substance; the others 
pertain to possession, trafficking, administration of substances, sample 
tampering, refusing to provide a sample, failing to provide whereabouts 
information, complicity in another’s use, and associating with a prohibited person 
(WADA, 2015: 18-24).  
Role of WADA and NADOs 
 WADA is best understood as an umbrella organisation that provides a 
framework for regulating numerous drugs and methods.  The WADC is not a 
single policy, but the regulatory blueprint from which the national and regional 
anti-doping organisations—NADOs and RADOs, respectively—implement and 
carry out anti-doping programs.  Though WADA is the body that is meant to 
harmonise anti-doping policies globally, each local anti-doping organisation must 
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work within local laws and budgets, and respond to the needs of athletes.  While 
the Prohibited List always applies to athletes of WADC signatory sports and 
countries, WADC enforcement can vary by NADO/RADO.  Areas where there 
may be difference include the amount and quality of educational materials, the 
TUE process, and in the number and frequency of tests carried out.   
 Anti-doping policies can be more intrusive for individuals than non-sports 
policies by collecting urine or blood samples, requiring information on individuals’ 
physical location for random testing, and policing athletes’ associates.  While 
some war on drugs policies did seek to deter and catch illicit drug users 
(Buchanan & Young, 2000), many national and international policies were 
intended to catch and prevent drug traffickers (Bagley, 1988; Tonry, 1994).  
Though trafficking is an anti-doping violation, individuals remain the central 
targets of WADA’s program.  WADA’s efforts are based on testing athletes’ 
biological samples for banned substances (WADA, 2015). Athletes are held to 
the standard of strict liability, meaning ‘it is not necessary that intent, Fault, 
negligence, or knowing Use on the Athlete’s part be demonstrated by the Anti-
Doping Organization in order to establish an anti-doping rule violation’ (WADA, 
2015: 141).  Because anti-doping tests cannot determine intent, athletes may test 
positive for a substance and receive a competition ban even if they did not intend 
to ingest the substance or seek to gain a performance benefit (de Hon & 
Coumans, 2007). If an athlete can show they took in the substance 
unintentionally, he or she may receive a reduced ban (WADA, 2015). In order to 
facilitate testing, athletes in the registered testing pool are required to keep local 
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testing agencies apprised of their whereabouts, including providing a one-hour 
time slot each day when they will be available in a specified place for testing 
(WADA, 2017b).   
 Anti-doping agencies may also sanction an athlete for associating with a 
support person1 who is currently serving an anti-doping ban. WADA does allow 
for non-sporting relationships (i.e. coach serving a ban who is also parent to an 
athlete), but athletes must show that the relationship is a non-sport association. 
WADA prohibits a sporting relationship with individuals who are ‘not subject to 
the authority of an Anti-Doping Organization, and where Ineligibility has not been 
addressed in a results management process pursuant to the WADC, has been 
convicted or found in a criminal, disciplinary or professional proceeding to have 
engaged in conduct which would have constituted a violation of anti-doping rules 
if WADC-compliant rules had been applicable to such Person’ (WADA, 2015: 23). 
Therefore, an athlete may receive a sanction for ‘associating’ with a person who 
is not subject to the WADC and who has not been sanctioned by a sports body.  
The intent of this regulation would appear to be preventing athletes from 
associating with doping traffickers or with support persons who may pressure 
athletes to use banned substances, though the enforcement remains at the 
individual athlete level.   
Prohibited substances 
                                                     
1 WADA defines Athlete Support Personnel as: ‘Any coach, trainer, manager, agent, 
team staff, official, medical, paramedical personnel, parent or any other Person working 
with, treating or assisting an Athlete participating in or preparing for sports 
Competition.’ 
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 Along with the WADC, WADA publishes an annually updated Prohibited 
List of all substances that are banned for athletes (WADA, 2017a). As its name 
implies, the list is the centrepiece of WADA’s prohibitionist approach to 
substance use.  Though some substances on the list are banned only in 
competition, the large majority is prohibited at all times (WADA, 2017).  Highly 
controversial inclusions on the list of Prohibited Substances are recreational 
drugs, including those without a likely performance enhancing effect, such as 
cannabis (WADA, 2017a).  Sports scholars have debated the inclusion of such 
substances (Henne, Koh & McDermott, 2013; Waddington et al., 2013) and 
noted the links between the war on drugs efforts and cannabis being banned 
(Kayser & Broers, 2012).  Cannabis is also a problematic inclusion given the 
associated-persons rule violation.  If an athlete has a relationship with any athlete 
support person (see footnote 1) who has been convicted of cannabis use or 
possession, it would follow that the relationship would be a rule violation.  Further 
complicating matters is the uneven liberalisation of recreational cannabis around 
the world, as this could lead to inconsistencies in enforcement.  
 An underlying assumption of this legalistic approach is that athletes will 
rationally weigh the decision to use banned substances—performance benefits 
versus the likelihood of being caught—and that tough punishments will deter 
athletes from doing so (Donovan, Egger, Kapernick & Mondoza, 2002; Strelan & 
Boeckmann, 2003). The WADC lays out the punishments if an individual commits 
an ADRV, including a four-year competition ban for a first time positive test, 
double the length of the previous maximum ban (WADA, 2015: 61).  While some 
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research has demonstrated that deterrence may effect doping decision-making 
(Donovan, Egger, Kapernick & Mendoza, 2002; Strelan & Boeckmann, 2006), 
others have found that contextual factors may be more effective than the fear of 
official sanction (Allen, Taylor, Dimeo, Dixon & Robinson, 2014; Petroczi & 
Aidman, 2008). In a study of Australian athletes, Stewart and Smith (2010) 
concluded that morality and deterrence-based polices are unlikely to end drug 
use in sport. Athletes on the cusp of elite status understood how legal 
enhancement use and banned substance use could be considered on the same 
spectrum, and saw similar reasons for each (Outram & Stewart, 2015). Indeed, 
some athletes may view doping as a next step from legal enhancement methods 
already in use (Petroczi & Aidman, 2008). Still others may see or suspect rivals 
of doping and feel pressured to do so themselves, resulting in doping becoming 
an acceptable norm among athletes (Stewart & Smith, 2010).   
Therapeutic Use Exemptions 
 Many national-level criminal drug policies have their roots in three UN 
Conventions on drugs—those in 1961, 1971, and 1988 (Fielding, 2014).  These 
required signatories to restrict the use of psychoactive substances to medical 
settings (Feilding, 2014; UNODC, 2013).  Illicit drugs were understood to have 
potential medical uses, even if specific countries prohibited medical use 
(Feilding, 2014).  Similarly, the list of Prohibited Substances includes drugs 
commonly used therapeutically (Fitch, 2013).  Recognizing this, WADA 
developed a policy of issuing TUEs.  TUEs are waivers allowing athletes to use 
banned substances when medically necessary for both acute and chronic 
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conditions. The necessity of TUEs seems clear—athletes should not be 
precluded from receiving necessary medical treatment, but athletes must 
demonstrate that necessity to prevent misuse.  However, critics of such 
exemptions argue that TUEs are easily abused and offer athletes an avenue for 
legal doping (Millar, 2016). 
Drug use among non-elites 
 It is clear from previous studies of adjudicated doping cases that non-
professional athletes in some sports do use banned substances (Henning & 
Dimeo, 2015).  However, reliable data on how many amateur athletes overall 
engage in doping is difficult to find and the level of knowledge of what is 
prohibited may vary considerably. One issue is how various forms of athletic 
participation are defined, as motivations and choice of substances may vary by 
participation.  Research into non-elite sport or fitness doping has focused in a 
few broad categories: bodybuilders, fitness enthusiasts, and non-elite sports 
competitors.  
 Bodybuilders are closely linked with anabolic steroid use in popular 
culture, where males are commonly depicted as monstrously muscled or 
suffering from so-called rages (Christiansen, Vinther & Liokaftos, 2016) and 
women as overly masculinised freaks (Shilling & Bunsell, 2009). Some relatively 
early survey work focused on young people and steroid use. Buckley et al (1988) 
found that 6.6% of 12th grade students had used these drugs. A study of anabolic 
steroid users revealed that athletic performance was not a motive for use while 
improving strength, gaining muscle mass, and improving overall attractiveness 
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did motivate use in a majority of respondents (Cohen, Collins, Darkes & 
Gwartney, 2007). Research with bodybuilders in South Wales found that steroid 
use was justified by reaching self-designed goals, demonstrating to doubters that 
use is not necessarily bad, and the relative lack of risk in use (Monaghan, 2002). 
Fitness enthusiasts—those who frequent fitness centres and/or exercise for non-
sport purposes—are not always immediately associated with doping.  However, 
research on use of PEDs among fitness centre users has demonstrated relatively 
high levels of use, though it is important to note that fitness centre users may 
have different goals than amateur or recreational sportspersons and therefore 
have different motivations for PED use.  A survey of 500 German fitness centre 
users found that 12.5% reported using various PEDs (Simon, Striegel, Aust, 
Dietz & Ulrich, 2006).  A similar study on Dutch fitness centre members reported 
a PED use prevalence rate of 8.2%, with stimulants for weight loss the highest 
category of use (Stubbe, Chorus, Frank, de Hon & van der Heijden, 2013).   
 Non-elite sportspersons are athletes who compete, but at levels below 
national teams and not to earn a livelihood.  Use among non-elite athletes has 
tended to focus on endurance athletes, as running, cycling, swimming, and multi-
sport events have large competitive fields with multiple levels of competition.  
Research into doping cases in American cycling, for instance, found that use 
behaviours varies by both competitive level and age group, with masters 
competitors (aged 40+) comprising their own use category (Henning & Dimeo, 
2015). A study of German amateur and recreational athletes found that the 
proportion of those who had doped at any point in their lives was between 3.35% 
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and 10.55% (Frenger, Pitsch & Emrich, 2016). Even athletes who do not use 
PEDs may understand the reasons one might engage doping, as well as actively 
seek out non-banned substances to gain a performance benefit.  For example, a 
study of Australian club-level cyclists reported that athletes perceived some form 
of drug use as necessary for advancing to the professional level (Outram & 
Stewart, 2015).  These cyclists also reported using supplements as a necessary 
component for success at lower levels of competition.  A study of non-elite road 
runners found athletes were willing to use a range of supplements for 
performance enhancing purposes, despite the risks of inadvertently ingesting 
banned substances (Henning, 2015).   
 Taken together, these studies demonstrate the wide variability in banned 
substance use among amateur, recreational, and fitness athletes.  While these 
studies show that these substances are being used, they also illustrate how a 
policy developed for elite or professional athletes may be ill suited to athletes 
whose goals may centre on appearance, anti-ageing, or other non-performance 
related areas.  Rather than focusing on the needs of these various populations, 
sport and anti-doping organizations have largely ignored these differences and 
instead begun to extend their policies, in whole, to lower and non-competitive 
levels.  
Amateur-targeted programs 
 National Anti-Doping Organizations (NADOs) are the bodies charged with 
carrying out anti-doping tests and issuing competition bans for athletes who 
commit an ADRV (WADA, 2015).  Under the 2015 WADC, NADOs’ purview was 
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expanded into the world of amateur and recreational sport and fitness (WADA, 
2015). The changes in global policy alongside expanded ideas of the remit and 
purpose for NADOs led to increasing calls for drug testing amateurs. USA 
Cycling (USAC), the national governing body of cycling events in the U.S., and 
New York Road Runners (NYRR), one of the largest running race organisers in 
the world, stepped up efforts to bring anti-doping testing to amateur athletes. In 
cycling, this was supported by high profile cases of older riders using EPO, 
stories considered important enough for national media coverage (Drier, 2012). 
 USAC, which has tested amateur athletes under its RaceClean program 
since 2013, added an anti-doping testing fee to licenses to cover the costs of 
increasing testing among amateurs (Cycling News, 2013; Whiteman, 2017).  
USAC reported that it exceeded its testing goal for the year 2016 to complete 
185 tests, more than tripling the number of tests conducted during the previous 
year (RaceClean, 2017). This is a sharp upturn in the number of tests to be sure, 
though the 2016 testing rate remains very low given USAC’s membership was 
more than 67,000 in 2015 (USA Cyling, 2016). The RaceClean webpage puts the 
program focus on cheating, clean sport, and fairness to clean athletes, though 
there is no mention of athlete health (USA Cycling, 2017).  
 NYRR introduced plans to expand its previous elite-focused testing 
program to amateur athletes, though focusing initially on top finishers only 
(NYRR, 2017a). NYRR has a history of not inviting elite athletes with a previous 
doping sanction to compete in their races, as well as providing funding for extra 
out of competition testing on athletes registered in the World Marathon Majors 
 18 
pool (NYRR, 2017). In its explanation for what the Run Clean program is meant 
to do and why, NYRR notes that healthy competition is a priority and seems to 
put it on equal footing with fairness (NYRR, 2017). NYRR plans to begin its 
testing program in early 2017.   
 Weakening these approaches is the lack of resources for in-competition 
testing and the absence of out-of-competition testing. Knowledgeable dopers can 
ensure any drugs used for training gains are washed out by event time. Perhaps 
more significantly it is far from clear how out-of-competition testing might be 
operationalised if there were sufficient funds to do so. Critics might argue that 
recreational athletes should not be governed in the same ways as professionals. 
In the following section, we describe the ways criminalisation proposals and 
debates about the fairness of TUEs have escalated the war on doping and the 
implications for amateur athletes.  Though both topics stem from concerns within 
elite sport, efforts to target amateur athletes under existing anti-doping policies 
would see these athletes included in such changes. 
Current debates: criminalisation and TUEs  
Criminalisation  
 Due to its position as a ‘private law foundation’ (WADA, 2017), WADA and 
its affiliated NADOs do not have broad legislative or police powers and have no 
jurisdiction outside of sport.  Anti-doping agencies must follow local laws and 
coordinate with police forces and other agencies for some investigative work 
(Hoberman, 2012).  In February 2015, WADA President Craig Reedie called for 
more countries to pass strict doping laws (Reuters, 2015). In a statement 
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following the Second International Conference on the Pharmaceutical Industry 
and the Fight Against Doping, Reedie noted that due to the widespread use of 
PEDs, doping has become a social issue rather than one relegated to sport 
(Reedie, 2015). As a wider response to doping, Reedie suggested, ‘If 
governments can introduce relevant laws, and applicable penalties to prevent 
these banned substances getting into the hands of athletes, then police will act 
and the scourge of doping can be prevented’ (Reedie, 2015).  It was unclear 
what Reedie was asking for specifically, but the language of laws, penalties, and 
police action seemed to indicate that some form of criminalisation was the goal.   
 National-level laws criminalising doping undermine one of WADA’s 
foundational purposes: harmonising anti-doping regulations globally (WADA, 
2015). To avoid conflicting rules and uneven application of rules between 
countries and sports, WADA is meant to standardise policies regarding, among 
other things, what substances and methods are banned, testing and analysis 
protocols, how sanctioning is determined and given out, and the appeals 
process.  National laws against doping, however, mean that athletes are treated 
differently depending on their nationality. As a non-governmental entity, WADA 
has no ability to ensure national laws are consistent or fairly applied.  
Enforcement may be uneven given differences in police purview, judicial 
processes, and varying requirements for evidence.  
 WADA issued a statement in October 2015 addressing criminalising 
doping, which sought to clarify the Agency’s position on doping laws. It states, 
‘the Agency does not believe that doping should be made a criminal offence for 
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athletes’ since it has a laid out process of tests, sanctions, and appeals within the 
sporting world (WADA, 2015).  It goes on to offer support for laws that ban and 
punish traffickers of doping substances before noting the effectiveness of 
criminal laws for ‘catching athlete support personnel that possess or traffic 
performance enhancing drugs’ because they are more willing to cooperate when 
threatened with prison (WADA, 2015).  What the statement failed to address is 
that the 2000 Italian law it referenced criminalised use and possession of doping 
substances by athletes in addition to non-athlete traffickers (Parlamento Italiano, 
2000).  While the penalties for supplying or trafficking doping substances are 
harsher, doping athletes may be fined or imprisoned (Parlamento Italiano, 2000).  
Similar laws exist in other countries, including broad doping-specific laws in 
Germany and France and earlier anti-steroid laws in the US and UK.  In 2016 
moves towards criminalisation accelerated in Kenya and the UK.    
 Much of the rationale for anti-doping generally and for criminalisation 
specifically, echoes the desire of non-sport drug warriors, especially those in the 
U.S. In the late 1980s the Office of National Drug Control Policy decided to use 
reductions in the instances of drug use as the most important metric in its 
strategy (ONDCP, 1989; Reuter, 2013).  This came at the expense of efforts to 
curtail harms related to use and instead continued the use of sentencing 
minimums for drug violations, leading to massive increases in the number federal 
prison inmates (Reuter, 2013). Despite widespread belief that the broader war on 
drugs has largely failed, anti-doping takes a similar punitive approach. WADA 
and national-level criminal laws intend to eradicate use through detection and 
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sanctioning (Sumner, 2017). Though the focus of current anti-doping efforts has 
largely been on elite and professional athletes competing at the highest levels 
and often as their livelihood, the shift to include amateurs opens the possibility of 
penalty to a huge new population of athletes.    
 Criminalising doping raises questions about how such laws would be 
enforced.  For instance, where the burden of proof at the CAS rests on the 
athlete, this is often not the case in non-sport criminal courts. The principle of 
strict liability would also be questioned, as intent is often a factor outside of sport.  
Intent is a prescient issue for doping cases, as a high proportion of cases are 
likely due to inadvertent use (de Hon, 2016). Threats of imprisonment are also 
troubling against the backdrop of the war on drugs.  Illicit drug policies led to 
some record high incarceration rates, from which some countries are only 
beginning to recover (Patten, 2016).  Given the newly expanded pool of athletes 
that would be subject to such laws, there is a risk that large numbers of athletes 
could end up jailed.  Incarceration for non-violent drug crimes has been shown to 
lead to increased engagement with crime and may limit career and other 
opportunities post-release (Buchanan & Young, 2000; Chin, 2002; Van Olphen, 
Eliason, Freudenberg & Barnes, 2009).  Whether such threats are likely to curb 
use remain unclear.   
 Criminal penalties for doping carry risks for amateur athletes, as they are 
less likely to be knowledgeable of anti-doping rules.  Amateur athletes must seek 
out anti-doping information on what substances they may and may not use and 
are often uninformed on what is banned in sport (Henning, 2015).  Athletes 
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across sporting levels have reported relying on a range of sources of information 
about doping (Erickson, McKenna & Backhouse, 2015; Johnson, Butryn & 
Masucci, 2013).  Unlike many elite athletes who have access to sports medicine 
professionals, amateurs may have less access to expert advice. A recent study 
of doping cases found that up to 40% may be from inadvertent use (de Hon, 
2016).  Athletes unaware that prescriptions or supplements may lead to a 
positive doping test are at a distinct disadvantage when it comes to remaining 
within the rules or avoiding prosecution under laws criminalising use.   
 Criminal laws may also be ineffective at actually countering doping among 
amateurs.  Given the high operating costs, amateur testing programs can only 
include a handful of finishers at each event.  In events that attract hundreds or 
thousands of participants, athletes can easily recognise that their chances of 
being found in violation of the criminal law are very low.  This runs counter to 
deterrence goals: if you are not a top finisher you are ostensibly allowed to 
continue any substance use unchecked.  Testing in this scheme would not deter 
athletes outside the top event finishers, as there is virtually no threat of being 
tested. Athletes may be even more unlikely to be deterred by the threat of 
criminal punishment, as they must first believe the risk of detection is high to be 
deterred by threats of retribution.  In this way, criminalising doping is unlikely to 
have a significant deterrence effect.    
 Criminalising doping also adds an informal punishment significant outside 
the sporting world—stigma. Doping ranks among the highest sporting taboos.  
Coomber (2013) observed ‘the label that being a doping cheat carries with it in 
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terms of both stigma and punishment rivals that of the heroin addict in their 
relative contexts’ (p. 16). Because doping is defined as committing an ADRV 
within the context of strict liability, athletes who test positive are dopers.  This is 
true regardless of intent or how the violation occurred.  Amateur athletes who are 
less likely to be knowledgeable about the finer points of avoiding insidious 
banned substances are at high risk of enduring the social costs of being labelled 
a doper.  Further, deterrence is unlikely when athletes are vulnerable to 
contaminated or mislabelled products resulting from poor regulation—a system 
outside their control.   
TUEs 
 The debate around TUEs was enhanced when athlete files were hacked 
from WADA’s 2016 Rio Olympics TUE database by the group known as Fancy 
Bear (WADA, 2016a). The group published data on 41 athletes representing 13 
countries, including some well-known international competitors (WADA, 2016).  
The focus of the leaked data was TUEs granted to athletes competing in Rio.  
This led to a media debate about the ‘grey area’ of doping (Millar, 2016), the 
various ways athletes could manipulate the TUE system to enhance performance 
(Game Theory, 2016), and the disparities between sports and countries in 
granting TUEs (Strashin, 2016).  WADA, sports federations, and athletes 
defended the athletes granted TUEs and the system under which such 
judgements were made (Guardian, 2016).  Many stressed that athletes with 
TUEs had followed the rules and gone through proper channels (Strashin, 2016).    
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 Fears around athletes seeking to abuse the TUE system for bettering their 
performance parallels fears that those seeking to legalise medical cannabis are 
really just looking for a legal way to misuse drugs (Bostwick, 2012; Seely, 
Prather, James & Moran, 2011).  The number of TUEs has grown rapidly, as the 
Sports Integrity Initiative (Brown, 2016) reported a 48% increase in the number of 
TUEs granted between 2014 and 2016. WADA explained this as being a function 
of better compliance with the Anti-Doping Administration and Management 
System (ADAMS) (Brown, 2016).  This seems to indicate that before the wide 
adoption of ADAMs, athletes may have neglected to seek out TUEs for banned 
medications.  This raises further questions about the effectiveness of infrequent 
out of competition testing for detecting use, as well as any deterrent effect of 
testing programs.   
 Criticising the TUE system and the athletes who use it is also at odds with 
the underpinning notion of the spirit of sport (WADA, 2015).  Athletes who go 
through the TUE process are within the rules of the sport, but also attempting to 
compete fairly, respectfully, and healthily.  Calling the TUE policy into question 
assumes the integrity of athletes is always suspect.  TUEs and the amateur-
specific Recreational Therapeutic Use Exemptions (RTUE) are given only when 
athletes can demonstrate to a review panel that a substance is required for 
medical reasons. TUEs are not all granted; USADA reported 402 TUEs were 
granted out of 653 applications in 2015 (USADA, 2015). Though the number of 
RTUEs is likely to go up (USADA does not provide numbers for RTUEs), it is 
unclear whether more exemptions being granted.  This is especially problematic 
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for amateur athletes who may be older, have chronic illnesses, and/or use legal 
lifestyle medications that may not meet the anti-doping definition of necessary. 
These include recreational cannabis as more localities liberalise policies 
governing use.  RTUEs are currently only available to athletes governed by 
USADA.  Amateur athletes in other countries, though unlikely targeted in the 
same way as USAC or NYRR athletes, must use the regular TUE processes 
originally designed for elites.    
 In a pragmatic sense, would, NYRR expect all 50,000+ participants in the 
marathon, for example, to complete the TUE process for all medications and 
have all their supplements checked as ‘clean’. The resources required for this far 
outweigh any benefit to the athletes or to ‘clean sport’. Nonetheless, if the 
organisation introduced random testing during the event, it remains possible that 
a low-ranking runner would test positive for an common substance like 
pseudoephdrine or methylexanamine. As such, transferring TUE policies to 
amateurs is fraught with a wide range of dilemmas. 
Recent cases 
Kenya and UK 
 Efforts to pass a criminal anti-doping law in Kenya came in the run up to 
the 2016 Summer Olympics, after WADA declared Kenya non-compliant with its 
WADC in May (WADA, 2016b).  Kenya is a perennial medal contender in track 
events, but the country had more than 40 athletes test positive for banned 
substances between 2011 and 2016.  The lack of a national testing system to 
carry out rigorous testing was also cause for WADA’s declaration of non-
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compliance (BBC, 2016).  In effort to avoid exclusion from the Olympics, Kenya 
agreed to pass anti-doping legislation to become WADC compliant.  The law 
created a national anti-doping agency and new criminal punishments for doping 
athletes (Sunday, 2016).  The law allows for monetary fines or a jail term of up to 
one year for athletes, and up to three years for medical personnel found 
supplying athletes with banned substances (National Council for Law Reporting, 
2016; Wanambisi & Isaboke, 2016).    
 Though the driving force behind the law was Olympics eligibility, Kenyan 
authorities sought to project toughness toward the treatment of doping athletes.  
As reported on the Kenyan government news website, Kenyan President Uhuru 
Kenyatta ‘made it clear that those who breach the law will be punished without 
fear or favour’ (MyGov, 2016).  These laws echo the tone of war on drugs 
policies criminalising illicit drug use, often in an effort for regulators to be viewed 
as taking a tough stance (Alexander, 2014).  
 Criminalisation debates in 2016 were not left to WADC non-compliant 
countries.  In December, the U.K. Parliament debated proposed legislative 
changes that would make doping a criminal offence.  A proposal sought to make 
it illegal for an athlete to use a banned PED, or for a coach or medical 
professional to supply it, with penalties going up to a six-month prison term 
(D’Arcy, 2016).  This followed calls earlier in the year from then-Prime Minister 
David Cameron to consider criminalising doping (MacLellan, 2016) and from 
former police officer Lord Stevens who said, ‘I believe some of the integrity 
breaches should be actually drafted into the criminal law, including the taking of 
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drugs. To safeguard the person who is taking the drugs and, more importantly, to 
ensure the sport is clean’ (Rumsby, 2016).  This view puts keeping sport ‘clean’ 
as the main anti-doping priority, not protecting athletes.   
USAC’s RaceClean program 
 Cases resulting from the expansion of WADA policies into amateur 
targeted programs highlight the tensions between anti-doping agencies and 
amateur athletes.  Previous research on doping cases across the competitive 
spectrum in US cycling demonstrated that positive tests for amateurs were often 
the result of cannabis, prescription medications, and inadvertent ingestion of 
substances (Henning & Dimeo, 2015).  In 2016 there were five sanction 
announcements from USADA out of USA Cycling’s RaceClean program, of which 
four were amateur cyclists (USA Cycling, 2017).  Of those four, three received 
reduced competition bans by demonstrating their positive tests were due to 
prescription medication each was ‘taking in a therapeutic does under the care of 
a qualified physician’ (USADA, 2016; 2016a; 2016b). Despite accepting each 
athlete’s explanation of using prescribed medications, all still received 
competition bans for failing to have a TUE. Strict liability means that even a 
successful defence will still lead to a ban. The impact of this regulation neither 
protects health nor reduces cheating.   
 While these athletes could have applied for TUEs to use their 
prescriptions while competing, there is no guarantee one would be granted.  One 
recently settled case involved the cyclist and triathlete, Sloane Teeple.  Before 
testing positive in 2013, Teeple had sought out and been denied a TUE three 
 28 
separate times in order to treat hypogonadism with prescription testosterone 
(Dreier, 2017).  After appealing his case to an arbitration panel, Teeple received 
notification in June 2015 that he had been granted a Recreational Competitor 
Therapeutic Use Exemption (RTUE) (Drier, 2016). This enabled him to compete 
while using his prescription.   
 RTUEs are a promising option for amateurs competing while using 
medically necessary therapies that happen to be banned. However, several 
issues with RTUEs prevent them from effectively preventing athletes from 
prescription-related positive tests.  The category for who is eligible for a RTUE is 
highly restrictive. These restrictions exclude those most likely to be selected for 
testing at a race, those who finish in a top spot or who place in their age groups. 
RTUEs are limited to: 
 ‘a Non-National Athlete who is not classified as a professional Athlete and who 
within the last 25 years (1) has not been in the USADA Registered Testing Pool 
or the Registered Testing Pool of an International Federation; (2) has not 
represented the United States in an International Event; (3) has not won a 
national or regional level Competition in any sport; (4) has not finished first, 
second or third in an age group category of any Event sanctioned by an NGB in 
which fifty (50) or more competitors have been entered in that category in the 
sport in which they are presently competing; and (5) has not won more than five 
hundred dollars (500.00 USD) in prize money in an Event in the sport in which 
they are presently competing’ (USADA, 2017: 4).   
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RTUEs also do not protect against athletes ingesting a banned substance 
inadvertently.  Elite athletes under the supervision of team doctors are not 
immune from accidental use (BBC Sport, 2016), but are nonetheless responsible 
under the strict liability principle.  For amateur athletes who may use common 
nutritional supplements there is a real risk of accidentally ingesting a banned 
substance (Judkins & Prock, 2014; Outram & Stewart, 2015a).   
 Cyclists may not be aware that they need a TUE. Though USA Cycling 
provides information about how to check on supplements and medications and 
information on when to apply for a TUE on its RaceClean page and in its 
updates, it is unclear how well these reach the targeted audience.  Athletes at 
lower competitive categories may assume that legal medications are allowed, 
that they are unlikely to be selected for testing at events, or that they are at low 
risk for a positive test if they avoid known doping substances. However, as these 
initial cases demonstrate, athletes may be unaware a TUE or RTUE may be 
necessary.   
 USADA’s introduction of RTUEs is a response to the challenges of testing 
amateur athletes. This development seems to have been done for the sake of 
efficiency—allowing lower level athletes to have their own standard rather than a 
wave of positive tests to adjudicate—and in response to challenges from athletes 
like Teeple. Other recent proposals, national-level laws criminalising doping and 
the validity of TUEs for clean athletes, seem to ignore the amateur context 
entirely.   
Conclusion:  Harm reduction as alternative 
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 Despite signs of a global shift away from war on drugs policies, the sport 
world is doubling down on the prohibit-detect-punish approach with a new 
population of amateur athletes.  The war on doping has been unsuccessful at 
eradicating doping from sports. Indeed, the scandals of 2016 alone demonstrate 
how far away that goal remains. Rather than heed the lessons from the war on 
drugs and try a different approach, anti-doping seems to be repeating many 
mistakes.  Moves to criminalise doping when high rates of inadvertent positive 
tests remain unresolved are problematic on their own (de Hon, 2016; de Hon & 
Coumons, 2007).  Coupled with expanding testing to include amateurs who are 
largely uneducated about anti-doping policies and the TUE system, but who use 
medications, recreational drugs, and lifestyle products, these proposals risk 
subjecting large numbers of athletes to the criminal justice system and the 
stigmas that follow from that into the non-sport world.   
 WADA has been reluctant to change its approach to anti-doping, 
maintaining that strict liability and lengthy competition bans are the most effective 
way to prevent athletes from doping. However, these policies were created with 
Olympic and professional level athletes in mind—not amateur and recreational 
athletes. It is clear amateurs are different from elites in their levels of competition, 
but also in their motivations for engaging in sport and their reasons for using 
banned substances, as discussed above.  It follows that anti-doping should not 
approach amateurs in the same way that it has elites.    
 We recommend sport take a different approach to amateur athletes: harm 
reduction.  Sports researchers have suggested harm reduction as an alternative 
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approach (Aubel & Ohl, 2014; Stewart & Smith, 2010), which has been shown to 
have user benefits for illicit drug users (Des Jarlais & Friedman, 1998; 
Toumbourou et al, 2007). A review of harm reduction-based studies found that 
the evidence in favour of a broad adoption of harm reduction as the guiding 
framework for drug use is sufficient (Ritter & Cameron, 2006). Indeed, it is the 
approach promoted by the UN and World Health Organization. While less a set 
of policies and more of an overall approach, a harm reduction-based anti-doping 
program would accept that banned substance use exists and will continue, 
therefore the focus should be on making use as safe as possible (Smith & 
Stewart, 2008). Using strategies of education, prevention, treatment, and medical 
advice, a harm reduction approach could engage with athletes rather than simply 
provide them with a set of morality-laden directives (Stewart & Smith, 2010).   
 An alternative approach is only feasible if anti-doping organisations are 
willing to acknowledge that amateurs are different from elites.  Developments like 
USADA’s RTUE are steps in this direction.  Rather than continuing to sink 
resources into a punitive system unlikely to catch or deter doping athletes, anti-
doping could fund research on safe use and develop better prevention and 
medical services for athletes, prioritising health over moral judgment.  This would 
also support a move away from a focus on ‘clean’ sport and towards one on 
healthy sport.          
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